Literature DB >> 16768637

Youths' and their parents' attitudes and experiences about participation in psychopharmacology treatment research.

Karen Dineen Wagner1, Melissa Martinez, Thomas Joiner.   

Abstract

OBJECTIVE: This study was designed to prospectively assess youths' and their parents' attitudes and experiences about participation in clinical treatment research.
METHOD: Pre- and post-questionnaires were administered to 90 youths ages 6-17 years with psychiatric disorders who participated in clinical treatment studies and their parents between August 2000 and March 2004.
RESULTS: The majority of youths (63%) and parents (90%) reported that finding out about the youth's problem and receiving treatment were the main reasons for participation in the clinical treatment studies. Percentage of youths and parents, respectively, who confirmed that informed consent issues were discussed were: Purpose of study (96%, 100%), study procedures (94%, 100%), alternative treatment (62%, 94%), and voluntary participation (89%, 99%). Most youths liked their treatment (98%), believed the study proceeded as expected (67%), were glad to have participated in this study (94%), and would participate in another study (65%). Most parents believed the quality of care was good (90%), the study proceeded as expected (96%), and were glad their child participated (99%).
CONCLUSIONS: The majority of youths and parents had a positive view about their experiences of participating in clinical treatment research, independent of whether or not the youth's psychiatric condition improved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16768637     DOI: 10.1089/cap.2006.16.298

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  6 in total

1.  Fragile X syndrome clinical trials: exploring parental decision-making.

Authors:  C S D'Amanda; H L Peay; A C Wheeler; E Turbitt; B B Biesecker
Journal:  J Intellect Disabil Res       Date:  2019-02-12

2.  Contrasting views of risk perception and influence of financial compensation between adolescent research participants and their parents.

Authors:  Lori Wiener; Adrienne Viola; Benjamin S Wilfond; David Wendler; Christine Grady
Journal:  J Empir Res Hum Res Ethics       Date:  2014-12-17       Impact factor: 1.742

Review 3.  Ethical issues in mental health research: the case for community engagement.

Authors:  James M Dubois; Brendolyn Bailey-Burch; Dan Bustillos; Jean Campbell; Linda Cottler; Celia B Fisher; Whitney B Hadley; Jinger G Hoop; Laura Roberts; Erica K Salter; Joan E Sieber; Richard D Stevenson
Journal:  Curr Opin Psychiatry       Date:  2011-05       Impact factor: 4.741

4.  Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.

Authors:  Karen Dineen Wagner; Joan Rosenbaum Asarnow; Benedetto Vitiello; Gregory Clarke; Martin Keller; Graham J Emslie; Neal Ryan; Giovanna Porta; Satish Iyengar; Louise Ritz; Jamie Zelanzny; Matthew Onorato; David Brent
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-01-17       Impact factor: 2.576

Review 5.  Understanding Ethical Issues of Research Participation From the Perspective of Participating Children and Adolescents: A Systematic Review.

Authors:  Stacey Crane; Marion E Broome
Journal:  Worldviews Evid Based Nurs       Date:  2017-02-16       Impact factor: 2.931

Review 6.  Motivations of children and their parents to participate in drug research: a systematic review.

Authors:  Krista Tromp; C Michel Zwaan; Suzanne van de Vathorst
Journal:  Eur J Pediatr       Date:  2016-04-04       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.